Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family
- PMID: 12591180
- DOI: 10.1016/s1043-2760(03)00005-5
Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family
Abstract
Anti-Müllerian hormone (AMH), also called Müllerian inhibiting substance, is a member of the transforming growth factor beta (TGF-beta) family that represses the development and function of reproductive organs. Not for nothing did Professor Alfred Jost, who first discovered its existence, christen it 'hormone inhibitrice'! Anti-Müllerian hormone is thought to exert its effects through two membrane-bound serine/threonine kinase receptors, type 2 and type 1. Upon ligand binding, these drive receptor-specific cytoplasmic substrates, the Smad molecules, into the nucleus where they act as transcription factors. A type 2 receptor specific for AMH was cloned through its homology with receptors of TGF-beta family members; the identity of the type 1 receptor(s) is controversial. Three type 1 receptors for bone morphogenetic proteins (BMPs) are possible candidates, each, not surprisingly, activating BMP-specific Smad molecules, Smads 1, 5 and 8. Each receptor could be involved, depending on the cellular context. To date, AMH signaling has been explored through BMP-specific genes, because a reporter gene related to a physiological AMH function and upregulated by the hormone has not yet been tested in a cell line strongly expressing the AMH receptor(s).
Similar articles
-
Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.Mol Cell Endocrinol. 2003 Dec 15;211(1-2):15-9. doi: 10.1016/j.mce.2003.09.006. Mol Cell Endocrinol. 2003. PMID: 14656471
-
Components of the anti-Müllerian hormone signaling pathway in gonads.Mol Cell Endocrinol. 2003 Dec 15;211(1-2):9-14. doi: 10.1016/j.mce.2003.09.005. Mol Cell Endocrinol. 2003. PMID: 14656470 Review.
-
Anti-Müllerian hormone and its receptors.Mol Cell Endocrinol. 2001 Jun 20;179(1-2):25-32. doi: 10.1016/s0303-7207(01)00467-1. Mol Cell Endocrinol. 2001. PMID: 11420127 Review.
-
Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.Mol Endocrinol. 2001 Jun;15(6):946-59. doi: 10.1210/mend.15.6.0664. Mol Endocrinol. 2001. PMID: 11376113
-
The serine/threonine transmembrane receptor ALK2 mediates Müllerian inhibiting substance signaling.Mol Endocrinol. 2001 Jun;15(6):936-45. doi: 10.1210/mend.15.6.0645. Mol Endocrinol. 2001. PMID: 11376112
Cited by
-
Characterization of the molecular mechanisms that govern anti-Müllerian hormone synthesis and activity.FASEB J. 2024 Jan;38(1):e23377. doi: 10.1096/fj.202301335RR. FASEB J. 2024. PMID: 38133902 Free PMC article.
-
AMH and other markers of ovarian function in patients with Turner syndrome - a single center experience of transition from pediatric to gynecological follow up.Front Endocrinol (Lausanne). 2023 Jun 29;14:1173600. doi: 10.3389/fendo.2023.1173600. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455919 Free PMC article. Review.
-
The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome.Diagnostics (Basel). 2023 Feb 27;13(5):907. doi: 10.3390/diagnostics13050907. Diagnostics (Basel). 2023. PMID: 36900051 Free PMC article. Review.
-
Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review.Nutrients. 2022 Aug 30;14(17):3578. doi: 10.3390/nu14173578. Nutrients. 2022. PMID: 36079834 Free PMC article. Review.
-
Anti-Müllerian Hormone Signal Transduction involved in Müllerian Duct Regression.Front Endocrinol (Lausanne). 2022 Jun 2;13:905324. doi: 10.3389/fendo.2022.905324. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721723 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
